• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANTHOGYR AXIOM IMPLANT X3 Ø4.6 X 6.5; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANTHOGYR AXIOM IMPLANT X3 Ø4.6 X 6.5; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number XT46060
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Codes Inflammation (1932); Fibrosis (3167); Hyperresponsive to stimuli (4538)
Date of Event 03/27/2026
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2025 in fdi 16.On (b)(6) 2026, loss of osseointegration was verified.The device was forwarded to the manufacturer.At the event the patient experienced: mobility, increased sensitivity and inflammation.No further patient complications were reported.
 
Additional Manufacturer Narrative
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.The loss of an endosseous dental implant after successful osseointegration and restoration is a known inherent risk of the procedure.Implants may have to be removed in case one or more of the implant success criteria are not met.Implant success criteria according to buser et al.(1991) are: 1.Absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia 2.Absence of a recurrent peri-implant infection with suppuration 3.Absence of implant mobility 4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOM IMPLANT X3 Ø4.6 X 6.5
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
ANTHOGYR
2237, avenue andré-lasquin
sallanches 74700
FR  74700
Manufacturer (Section G)
ANTHOGYR
2237, avenue andré-lasquin
sallanches 74700
FR   74700
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
9787472509
MDR Report Key25281696
Report Number0008020776-2026-000562
Device Sequence Number15973876
Product Code DZE
UDI-Device Identifier03663394483605
UDI-Public03663394483605
Combination Product (Y/N)N
Initial Reporter CountryRS
PMA/510(K) Number
K230104
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 05/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberXT46060
Device Lot NumberHAZW9
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/26/2026
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/26/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/23/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age41 YR
Patient SexMale
-
-